Annual Call for Drug Applications to be Submitted for Funding Consideration – 2023

Start on 03 Oct 2022
End on 31 Jan 2023

A- A+

The Ministry of Health (MOH) invites healthcare institutions to submit drug applications for:

  • consideration by the MOH Drug Advisory Committee (DAC) to list on the MOH List of Subsidised Drugs (SDL or MAF) and/or Cancer Drug List (CDL), or
  • consideration by the Rare Disease Fund Committee (RDFC) to include in the Rare Disease Fund (RDF).

Clinicians may email for more information about the drug application process.

Audience Type : Doctor ; Pharmacist ; Nurse